Management of immune thrombocytopenia in France before the era of thrombopoietin receptor agonists;Prise en charge du purpura thrombopénique immunologique en France avant la mise à disposition des agonistes du récepteur à la thrombopoïétine

Revue de Medecine Interne

Volumn 33, Issue 6, 2012, Pages 305-310

  Michel, M ^a   Doz, M ^b   Leclerc Teffahi, S ^c   Detournay, B ^b   Levy Bachelot L ^c  

^a HENRI MONDOR HOSPITAL   (France)

^b CEMKA EVAL   (France)

^c GLAXOSMITHKLINE   (France)

Author keywords

Corticosteroids; Immune thrombocytopenia; Splenectomy; Treatment line; Treatment regimen

Indexed keywords

CORTICOSTEROID; CYTOKINE RECEPTOR AGONIST; IMMUNOGLOBULIN; RITUXIMAB; THROMBOPOIETIN RECEPTOR; THROMBOPOIETIN RECEPTOR AGONIST; UNCLASSIFIED DRUG;

ADULT; ARTICLE; AUTOIMMUNE THROMBOCYTOPENIA; CHRONIC DISEASE; FEMALE; FRANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OBSERVATIONAL STUDY; SPLENECTOMY;

ADRENAL CORTEX HORMONES; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; AUTOIMMUNE DISEASES; FEMALE; FRANCE; GLUCOCORTICOIDS; HEMATOLOGY; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MALE; MIDDLE AGED; RECEPTORS, THROMBOPOIETIN; RETROSPECTIVE STUDIES; THROMBOCYTOPENIA; YOUNG ADULT;

EID: 84862223346     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2012.02.003     Document Type: Article

References (18)

1. Rodeghiero F., Stasi R., Gernsheimer T., Michel M., Provan D., Arnold D.M., et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood 2009, 113:2386-2393.
2. Stasi R., Evangelista M.L., Stipa E., Buccisano F., Venditti A., Amadori S. Idiopathic thrombocytopenic purpura:current concepts in pathophysiology and management. Thromb Haemost 2008, 99:4-13.
3. MCMillan R. Therapy for adults with refractory chronic immune thrombocytopenic purpura. Ann Intern Med 1997, 126:307-314.
4. Frederiksen H., Schmidt K. The incidence of idiopathic thrombocytopenic purpura in adults increases with age. Blood 1999, 94:909-919.
5. Neylon A.J., Sauders P.W., Howard M.R., Proctor S.J., Taylor P.R. Clinically significant newly presenting autoimmune thrombocytopenic purpura in adults:a prospective study of a population-based cohort of 245 patients. Br J Haematol 2003, 122:966-974. on behalf of the Northern Region Haematology Group.
6. Godeau B. Purpura thrombopénique immunologique:physiopathologie et traitement. Transfus Clin Biol 2009, 16:101-105.
7. Agence nationale d'accréditation et d'évaluation en santé (ANAES) et la Société française d'hématologie. Référentiel d'auto-évaluation des pratiques en hématologie. Purpura thrombopénique auto-immun. Décembre 2004.
8. Purpura thrombopénique immunologique de l'enfant et de l'adulte, Protocole national de diagnostic et de soins, Guide-affection de longue durée, Haute Autorité de santé, octobre 2009.
9. Bierling P., Godeau B. Intravenous immunoglobulin and autoimmune thrombocytopenic purpura: 22 years on. Vox Sang 2004, 86:8-14.
10. Kojouri K., Vesely S.K., Terrell D.R., George J.N. Splenectomy for adult patients with idiopathic thrombocytopenic purpura:a systematic review to assess long-term platelet count responses, prediction of response, and surgical complications. Blood 2004, 104:2623-2634.
11. AP-HP. Comité de Juste prescription. Avis du 3 octobre 2008 version 3.
12. Provan D., Stasi R., Newland A.C., Blanchette V.S., Bolton-Maggs P., Bussel J.B., et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood 2010, 115:168-186.
13. Rodeghiero F., Besalduch J., Michel M., Provan D., Grotzinger K., Thompson G. Treatment practices in adults with chronic immune thrombocytopenia - a European perspective. Eur J Haematol 2010, 84:160-168.
14. Audia S., Lakomy D., Guy J., Leguy-Seguin V., Berthier S., Aho S., et al. Traitement du purpura thrombopénique immunologique : étude rétrospective de 40 patients. Rev Med Interne 2010, 31:337-344.
15. Fogarty P.F., Segal J.B. The epidemiology of immune thrombocytopenic purpura. Curr Opin Hematol 2007, 14:515-519.
16. Feudjo-Tepie M.A., Le Roux G., Beach K.J., Bennett D., Robinson N.J. Comorbidities of Idiopathic Thrombocytopenic Purpura: A Population-Based Study. Adv Hematol 2009, 2009:963506.
17. Schwartz J., Leber M.D., Gillis S., Giunta A., Eldor A., Bussel J.B. Long term follow-up after splenectomy performed for immune thrombocytopenic purpura (ITP). Am J Hematol 2003, 72:94-98.
18. Khellaf M. Prise en charge du purpura thrombopénique immunologique de l'adulte. Rev Med Interne 2010, 31(Suppl 3):S329-S332.